- Home
- HOLO vs IXHL Comparison
HOLO vs IXHL Comparison
Compare HOLO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOLO
- IXHL
- Stock Information
- Founded
- HOLO 2018
- IXHL 2001
- Country
- HOLO China
- IXHL Australia
- Employees
- HOLO N/A
- IXHL N/A
- Industry
- HOLO Computer Software: Programming Data Processing
- IXHL
- Sector
- HOLO Technology
- IXHL
- Exchange
- HOLO Nasdaq
- IXHL Nasdaq
- Market Cap
- HOLO 66.3M
- IXHL 54.5M
- IPO Year
- HOLO N/A
- IXHL N/A
- Fundamental
- Price
- HOLO $5.61
- IXHL $0.54
- Analyst Decision
- HOLO
- IXHL
- Analyst Count
- HOLO 0
- IXHL 0
- Target Price
- HOLO N/A
- IXHL N/A
- AVG Volume (30 Days)
- HOLO 1.7M
- IXHL 114.1M
- Earning Date
- HOLO 08-10-2023
- IXHL 11-13-2025
- Dividend Yield
- HOLO N/A
- IXHL N/A
- EPS Growth
- HOLO N/A
- IXHL N/A
- EPS
- HOLO 13.81
- IXHL N/A
- Revenue
- HOLO $44,840,587.00
- IXHL $98,000.00
- Revenue This Year
- HOLO N/A
- IXHL $2,538.49
- Revenue Next Year
- HOLO N/A
- IXHL $249.95
- P/E Ratio
- HOLO $0.39
- IXHL N/A
- Revenue Growth
- HOLO 37.10
- IXHL N/A
- 52 Week Low
- HOLO $4.16
- IXHL $0.08
- 52 Week High
- HOLO $375.20
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- HOLO 64.11
- IXHL 49.14
- Support Level
- HOLO $4.42
- IXHL $0.51
- Resistance Level
- HOLO $5.92
- IXHL $0.59
- Average True Range (ATR)
- HOLO 0.36
- IXHL 0.05
- MACD
- HOLO 0.14
- IXHL -0.01
- Stochastic Oscillator
- HOLO 80.50
- IXHL 19.57
About HOLO MicroCloud Hologram Inc.
MicroCloud Hologram Inc, through its subsidiaries, is mainly engaged in holographic Technology. It includes Holographic solutions and Holographic technology services. The company also provides holographic digital twin technology services for customers and has built a holographic digital twin technology resource library. Geographically company is operating in single segment, China.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.